US2023270142A1PendingUtilityA1

Composition containing equol and ornithine

Assignee: OTSUKA PHARMA CO LTDPriority: Dec 6, 2005Filed: Sep 29, 2022Published: Aug 31, 2023
Est. expiryDec 6, 2025(expired)· nominal 20-yr term from priority
A23V 2400/21A23L 11/07A23L 33/10A61P 3/00A23V 2250/21172A23V 2250/0636A23L 11/50A23L 33/105A61K 8/498A61Q 19/00A61K 8/9789A23V 2002/00A61K 2800/85A61Q 19/02A61K 8/97A61K 31/352A61K 36/48A61K 2236/19A61Q 19/10A61P 1/00A61P 13/08A61P 15/00A61P 15/12A61P 19/10A61P 25/24A61P 35/00A61P 3/04A61P 3/06A61P 5/30A61P 5/32A61P 7/10
80
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An object of the invention is to provide an equol-containing fermented soybean hypocotyl material that is useful for foods, pharmaceutical preparations, cosmetic products, etc.The equol-containing fermented soybean hypocotyl material of the invention is obtained by fermenting soybean hypocotyls using at least one microorganism having an equol-producing ability by utilizing at least one daidzein compound selected from the group consisting of diadzein glycosides, daidzein, and dihydrodaidzein.

Claims

exact text as granted — not AI-modified
1 - 6 . (canceled) 
     
     
         7 . An equol-containing fermented soybean hypocotyl material obtained by fermenting soybean hypocotyls using at least one microorganism having an equol-producing ability by utilizing at least one daidzein compound selected from the group consisting of daidzein glycosides, daidzein, and dihydrodaidzein. 
     
     
         8 . The equol-containing fermented soybean hypocotyl material according to  claim 7 , wherein said at least one microorganism is a lactic acid bacterium of the genus  Lactococcus.    
     
     
         9 . The equol-containing fermented soybean hypocotyl material according to  claim 7 , wherein said at least one microorganism belongs to  Lactococcus garvieae.    
     
     
         10 . The equol-containing fermented soybean hypocotyl material according to  claim 7 , which contains 0.1 to 20 wt % of equol per total weight of dry fermented soybean hypocotyl material. 
     
     
         11 . The equol-containing fermented soybean hypocotyl material according to  claim 7 , which further contains daidzein compounds, genistin compounds, genistein compounds, glycitin compounds and glycitein compounds. 
     
     
         12 . The equol-containing fermented soybean hypocotyl material according to  claim 7 , which further contains ornithine. 
     
     
         13 . A food containing the equol-containing fermented soybean hypocotyl material of  claim 7 . 
     
     
         14 . The food according to  claim 13 , which is a dietary supplement. 
     
     
         15 . The food according to  claim 13 , which contains 0.1 to 90 g of the equol-containing fermented soybean hypocotyl material per 100 g of the food. 
     
     
         16 . A pharmaceutical preparation containing the equol-containing fermented soybean hypocotyl material of  claim 7 . 
     
     
         17 . The pharmaceutical preparation according to  claim 16 , which is used for preventing or treating menopausal disorders, osteoporosis, prostatic hypertrophy, or metabolic syndrome. 
     
     
         18 . A pharmaceutical preparation according to  claim 16 , which is used for lowering the blood cholesterol level. 
     
     
         19 . Use of a fermented soybean hypocotyl material of  claim 7  for producing preparations for preventing or treating menopausal disorders, osteoporosis, prostatic hypertrophy, or metabolic syndrome. 
     
     
         20 . Use of a fermented soybean hypocotyl material of  claim 7  for producing preparations for lowering the blood cholesterol level. 
     
     
         21 . A method for treating menopausal disorders comprising the step of administering an effective amount of a fermented soybean hypocotyl material of  claim 7  to a patient suffering from menopausal disorders. 
     
     
         22 . A method for lowering the blood cholesterol level comprising the step of administering an effective amount of a fermented soybean hypocotyl material of  claim 7  to a patient who is in need of lowering the blood cholesterol level. 
     
     
         23 . A cosmetic product containing the fermented soybean hypocotyl material of  claim 7 . 
     
     
         24 . A cosmetic product according to  claim 23 , which contains 0.1 to 10 g of the fermented soybean hypocotyl material per 100 g of cosmetic product. 
     
     
         25 . A method for producing an equol-containing fermented soybean hypocotyl material comprising the step of fermenting soybean hypocotyls using at least one microorganism having an equol-producing abilityby utilizing at least one daidzein compound selected from the group consisting of daidzein glycosides, daidzein, and dihydrodaidzein.

Join the waitlist — get patent alerts

Track US2023270142A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.